A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting
Adjuvant treatment for patients with early stage colorectal cancer (eCRC) is currently based on suboptimal risk stratification, especially for elderly patients. Metabolomics may improve the identification of patients with residual micrometastases after surgery. In this retrospective study, we hypoth...
Main Authors: | Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, Vanessa Calamai, Annamaria Parnofiello, Giulia Di Pierro, Ilenia Migliaccio, Stefano Cantafio, Maddalena Baraghini, Giuseppe Mottino, Dimitri Becheri, Francesca Del Monte, Elisangela Miceli, Amelia McCartney, Angelo Di Leo, Claudio Luchinat, Laura Biganzoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2762 |
Similar Items
-
Exploring Serum NMR-Based Metabolomic Fingerprint of Colorectal Cancer Patients: Effects of Surgery and Possible Associations with Cancer Relapse
by: Alessia Vignoli, et al.
Published: (2021-11-01) -
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
by: Alessia Vignoli, et al.
Published: (2021-04-01) -
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
by: Ilenia Migliaccio, et al.
Published: (2022-02-01) -
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
by: Lorenzo Rossi, et al.
Published: (2018-12-01) -
Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice
by: Amelia McCartney, et al.
Published: (2019-07-01)